Abstract
Endovascular stent use has expanded at an unprecedented rate; they are currently being used in more than 50% of coronary angioplasty procedures. This rapid acceptance is due to excellent in-hospital results coupled with improved long-term clinical endpoints from small randomized trials, which have investigated only a few stent designs in small patient subsets. The generalized use of stents in all lesions has yet to be substantiated. Current limitations of stents include the occurrence of subacute thrombosis, late neointima proliferation, and design issues such as stent visibility and deliverability. New designs, including stent coatings and stents for bifurcations, will increase the use of stents for endovascular procedures.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
